100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Dermatomycoses caused by zoophilic strains, particularly Trichophyton mentagrophytes, are becoming increasingly challenging to treat due to the emergence of terbinafine-resistant strains. These resistances are largely attributed to mutations in the squalene epoxidase (SQLE) gene, the target site of terbinafine. As a result, there is a growing demand for alternative antifungal treatments.
Study Objective
To evaluate the in vivo therapeutic efficacy of luliconazole 1% cream compared to terbinafine 1% cream in treating infections caused by T. mentagrophytes, and to assess their antifungal activity through in vitro susceptibility testing.
Methods
Patients were evaluated using:
KOH with DMSO direct microscopy
qPCR with pan-dermatophyte primers
Fungal culture
Additionally, in vitro minimum inhibitory concentrations (MICs) were determined for both luliconazole and terbinafine.
Key Findings
Luliconazole showed significantly superior antifungal efficacy.
MIC (Geometric Mean):
A 28-day course of topical luliconazole achieved complete clinical and microbiological cure in all patients, with full eradication of the pathogen.
Conclusion
With the rising incidence of terbinafine-resistant T. mentagrophytes infections, luliconazole 1% cream emerges as an effective and reliable topical antifungal alternative. Its superior potency and high eradication rate underscore its value in the management of difficult-to-treat zoophilic dermatomycoses.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.